Inspiratory Muscle Training for Exercise-Induced Asthma
(IMT_EIB Trial)
Trial Summary
What is the purpose of this trial?
Due to the lack of studies examining the impact of inspiratory muscle training (IMT) on the severity of exercise-induced bronchoconstriction (EIB) and exercise performance, the specific aim of this study is to assess the efficacy of flow-resistive IMT on EIB severity and symptoms, short-acting beta-2-agonist medication use, operating lung volumes, respiratory and limb locomotor muscle deoxygenation during constant-load cycling exercise, exertional dyspnea, and cycling time-trial performance.
Will I have to stop taking my current medications?
Yes, you will need to stop taking certain medications. The trial excludes participants who are currently taking asthma maintenance medications, SSRIs, ADHD medication, and those who chronically consume pain medication.
What data supports the effectiveness of the treatment PrO2Fit Device, PrO2Fit Device, Inspiratory Muscle Trainer for exercise-induced asthma?
Inspiratory muscle training (IMT) has been shown to improve muscle strength and endurance in asthma patients, leading to better asthma symptoms, fewer hospital visits, and reduced medication use. Studies also show that similar devices and training methods can enhance exercise capacity and quality of life in patients with respiratory conditions.12345
Is inspiratory muscle training safe for humans?
How does the PrO2Fit Device treatment for exercise-induced asthma differ from other treatments?
The PrO2Fit Device is unique because it focuses on strengthening the respiratory muscles through inspiratory muscle training, which involves breathing against resistance to improve muscle strength and endurance. This approach is different from typical asthma treatments that often rely on medications to open airways or reduce inflammation.145910
Research Team
Tim Mickleborough, Ph.D.
Principal Investigator
Indiana University
Eligibility Criteria
This trial is for competitive recreational or college athletes aged 18-35 with mild to moderate persistent asthma or EIB, a BMI of 18.5-28, and at least 1-2 years of cycling experience. They must have an FEV1 >65% predicted and not be on asthma maintenance meds, SSRIs, ADHD meds, painkillers regularly, fish oil supplements, nor have cardiovascular or other specified diseases.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo inspiratory muscle training (IMT) or sham IMT for 8 weeks, focusing on improving inspiratory muscle strength and endurance.
Follow-up
Participants are monitored for changes in exercise-induced bronchoconstriction severity, inspiratory muscle strength, and cycling performance.
Treatment Details
Interventions
- PrO2Fit Device
Find a Clinic Near You
Who Is Running the Clinical Trial?
Indiana University
Lead Sponsor